Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications

Open access
Penninx, Brenda W. J. H., Lange, Sjors M. M. · 2018 · Dialogues in Clinical Neuroscience

Abstract

Psychiatric patients have a greater risk of premature mortality, predominantly due to cardiovascular diseases (CVDs). Convincing evidence shows that psychiatric conditions are characterized by an increased risk of metabolic syndrome (MetS), a clustering of cardiovascular risk factors including dyslipidemia, abdominal obesity, hypertension, and hyperglycemia. This increased risk is present for a range of psychiatric conditions, including major depressive disorder (MDD), bipolar disorder (BD), schizophrenia, anxiety disorder, attention-deficit/hyperactivity disorder (ADHD), and posttraumatic stress disorder (PTSD). There is some evidence for a dose-response association with the severity and duration of symptoms and for a bidirectional longitudinal impact between psychiatric disorders and MetS. Associations generally seem stronger with abdominal obesity and dyslipidemia dysregulations than with hypertension. Contributing mechanisms are an unhealthy lifestyle and a poor adherence to medical regimen, which are prevalent among psychiatric patients. Specific psychotropic medications have also shown a profound impact in increasing MetS dysregulations. Finally, pleiotropy in genetic vulnerability and pathophysiological mechanisms, such as those leading to the increased central and peripheral activation of immunometabolic or endocrine systems, plays a role in both MetS and psychiatric disorder development. The excess risk of MetS and its unfavorable somatic health consequences justifies a high priority for future research, prevention, close monitoring, and treatment to reduce MetS in the vulnerable psychiatric patient.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.31887/dcns.2018.20.1/bpenninx

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Risk factors for metabolic syndrome dysregulations in psychiatric patients (left box) and the potential (future) clinical implications needed to minimize the unfavorable impact of these risk factors (middle box). HPA-axis, hypothalamic-pituitary-adrenal axis; MetS, metabolic syndrome
Figure 1. Risk factors for metabolic syndrome dysregulations in psychiatric patients (left box) and the potential (future) clinical implications needed to minimize the unfavorable impact of these risk factors (middle box). HPA-axis, hypothalamic-pituitary-adrenal axis; MetS, metabolic syndromeCC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 78 references

Research works printed but not linked: 3

  1. Newcomer JW., 2007, J Clin Psychiatry., 68, 8
  2. Vallecillo G., SubstAbus. 2017 August 3. Epub ahead of print. doi:10. 1080/08897077.2017.1363122.
  3. Sari-Sarraf V., 2015, Int J Gen Med., 8, 203

Cited by

See all 599

Metadata

Authors
Penninx, B. W. J. H., & Lange, S. M. M.
Affiliations
GGZ inGeest (NL)
Corresponding author
Penninx, Brenda W. J. H.
Venue
Dialogues in Clinical Neuroscience
Published
2018-03-31
Volume
20
Issue
1
Pages
63-73
ISSN
  • 1294-8322 (ISSN-L)
  • 1958-5969
OpenAlex
W2920711593
Cited by
566
References
78
Citations by year
2026: 68 · 2025: 100 · 2024: 106 · 2023: 92 · 2022: 64 · 2021: 72 · 2020: 41 · 2019: 18 · 2018: 3
FWCI
26.66
Type
journal article
Language
en
Open access
Locations
  • Dialogues in Clinical Neuroscience (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords
metabolic syndrome, mental illness, cardiovascular risk, major depressive disorder, bipolar disorder, schizophrenia, anxiety disorders, attention deficit hyperactivity disorder, post-traumatic stress disorder, abdominal obesity, dyslipidemia, hypertension, hyperglycemia, psychotropic drugs, adverse drug reactions, lifestyle factors, medication adherence, genetic susceptibility, immunometabolism, endocrine system, premature mortality
MeSH terms
Mental Disorders, Bipolar Disorder, Major Depressive Disorder, Depressive Disorder, Major, Humans, Psychotropic Drugs, Schizophrenia, Stress Disorders, Post-Traumatic, Metabolic Syndrome, Risk Reduction Behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications. https://app.cochat.ai/papers/10.31887/dcns.2018.20.1/bpenninx
The paper
Penninx, B. W. J. H., & Lange, S. M. M. (2018). Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2018.20.1/bpenninx

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.